2024 Q3 Form 10-Q Financial Statement
#000181957424000039 Filed on August 07, 2024
Income Statement
| Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
|---|---|---|---|
| Revenue | $126.1M | $116.2M | $120.6M |
| YoY Change | 2.5% | -3.63% | -8.05% |
| Cost Of Revenue | $50.00M | $42.95M | $47.56M |
| YoY Change | 5.5% | -9.69% | -14.06% |
| Gross Profit | $76.11M | $73.27M | $73.04M |
| YoY Change | 0.62% | 0.31% | -3.66% |
| Gross Profit Margin | 60.35% | 63.05% | 60.57% |
| Selling, General & Admin | $81.81M | $83.86M | $87.04M |
| YoY Change | -5.64% | -3.66% | -9.29% |
| % of Gross Profit | 107.48% | 114.46% | 119.17% |
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | $2.800M | $2.879M | $2.868M |
| YoY Change | -8.79% | 0.38% | -12.08% |
| % of Gross Profit | 3.68% | 3.93% | 3.93% |
| Operating Expenses | $81.81M | $83.86M | $87.04M |
| YoY Change | -5.69% | -3.66% | -9.29% |
| Operating Profit | -$5.696M | -$10.59M | -$14.00M |
| YoY Change | -48.68% | -24.36% | -30.46% |
| Interest Expense | $666.0K | $768.0K | -$758.0K |
| YoY Change | -51.24% | -201.32% | -45.43% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$233.0K | -$215.0K | $1.583M |
| YoY Change | -276.52% | -113.58% | -74.13% |
| Pretax Income | -$5.263M | -$10.04M | -$11.66M |
| YoY Change | -49.09% | -13.92% | -24.31% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$5.263M | -$10.04M | -$11.66M |
| YoY Change | -49.09% | -13.92% | -24.31% |
| Net Earnings / Revenue | -4.17% | -8.64% | -9.67% |
| Basic Earnings Per Share | -$0.03 | -$0.06 | -$0.07 |
| Diluted Earnings Per Share | -$0.03 | -$0.06 | -$0.07 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 173.5M shares | 175.6M shares | 178.3M shares |
| Diluted Shares Outstanding | 175.1M shares | 175.6M shares | 177.7M shares |
Balance Sheet
| Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $115.2M | $117.8M | $163.9M |
| YoY Change | -28.2% | -28.14% | -7.51% |
| Cash & Equivalents | $115.2M | $117.8M | $163.9M |
| Short-Term Investments | |||
| Other Short-Term Assets | $11.07M | $6.935M | $5.153M |
| YoY Change | 157.44% | 34.58% | -61.91% |
| Inventory | $88.44M | $80.43M | $112.5M |
| Prepaid Expenses | |||
| Receivables | $16.90M | $7.100M | $5.128M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $231.6M | $212.2M | $286.7M |
| YoY Change | -19.18% | -25.97% | -19.68% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $23.43M | $23.54M | $38.37M |
| YoY Change | -18.43% | -38.65% | -48.55% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | $8.010M | $10.73M | $5.582M |
| YoY Change | -30.98% | 92.26% | |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $8.220M | $9.413M | $7.416M |
| YoY Change | 13.05% | 26.93% | 68.01% |
| Total Long-Term Assets | $69.92M | $75.52M | $87.18M |
| YoY Change | -15.11% | -13.38% | 5.44% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $231.6M | $212.2M | $286.7M |
| Total Long-Term Assets | $69.92M | $75.52M | $87.18M |
| Total Assets | $301.6M | $287.7M | $373.9M |
| YoY Change | -18.27% | -23.04% | -14.96% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $33.70M | $10.83M | $19.55M |
| YoY Change | 29.18% | -44.62% | -43.06% |
| Accrued Expenses | $38.75M | $39.39M | $34.70M |
| YoY Change | 9.15% | 13.52% | 10.32% |
| Deferred Revenue | $23.40M | $26.50M | $26.30M |
| YoY Change | -3.7% | 0.76% | |
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $95.89M | $76.72M | $80.59M |
| YoY Change | 11.55% | -4.81% | -19.62% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $40.13M | $40.03M | $81.41M |
| YoY Change | -50.82% | -50.83% | 6.63% |
| Other Long-Term Liabilities | $2.236M | $1.735M | $3.244M |
| YoY Change | -49.05% | -46.52% | -94.29% |
| Total Long-Term Liabilities | $42.36M | $41.76M | $84.65M |
| YoY Change | -50.73% | -50.67% | -36.44% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $95.89M | $76.72M | $80.59M |
| Total Long-Term Liabilities | $42.36M | $41.76M | $84.65M |
| Total Liabilities | $178.0M | $159.7M | $211.9M |
| YoY Change | -18.36% | -24.65% | -9.22% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$362.2M | -$356.8M | -$321.5M |
| YoY Change | 9.16% | 10.99% | |
| Common Stock | $1.000K | $1.000K | $1.000K |
| YoY Change | 0.0% | 0.0% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $123.6M | $128.1M | $161.9M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $301.6M | $287.7M | $373.9M |
| YoY Change | -18.27% | -23.04% | -14.96% |
Cashflow Statement
| Concept | 2024 Q3 | 2024 Q2 | 2023 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$5.263M | -$10.04M | -$11.66M |
| YoY Change | -49.09% | -13.92% | -24.31% |
| Depreciation, Depletion And Amortization | $2.800M | $2.879M | $2.868M |
| YoY Change | -8.79% | 0.38% | -12.08% |
| Cash From Operating Activities | $2.774M | $1.792M | -$10.74M |
| YoY Change | -1.63% | -116.68% | -38.36% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $1.808M | $2.043M | $2.972M |
| YoY Change | -7.76% | -31.26% | -162.77% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$1.808M | -$2.043M | -$2.972M |
| YoY Change | -7.76% | -31.26% | -37.23% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -2.182M | -$4.300M | -$221.0K |
| YoY Change | -50.97% | 1845.7% | -22200.0% |
| NET CHANGE | |||
| Cash From Operating Activities | 2.774M | $1.792M | -$10.74M |
| Cash From Investing Activities | -1.808M | -$2.043M | -$2.972M |
| Cash From Financing Activities | -2.182M | -$4.300M | -$221.0K |
| Net Change In Cash | -1.216M | -$4.530M | -$13.93M |
| YoY Change | -66.13% | -67.48% | -37.13% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $2.774M | $1.792M | -$10.74M |
| Capital Expenditures | $1.808M | $2.043M | $2.972M |
| Free Cash Flow | $966.0K | -$251.0K | -$13.71M |
| YoY Change | 12.33% | -98.17% | 8.06% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2024Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
42946000 | usd |
| CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
47555000 | usd |
| CY2024Q2 | us-gaap |
Gross Profit
GrossProfit
|
73266000 | usd |
| CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
73036000 | usd |
| CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
63426000 | usd |
| CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
69421000 | usd |
| CY2024Q2 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
20432000 | usd |
| CY2023Q2 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
17619000 | usd |
| CY2024Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
83858000 | usd |
| CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
87040000 | usd |
| CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10592000 | usd |
| CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14004000 | usd |
| CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
175561535 | shares |
| CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
175561535 | shares |
| CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3225000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
2000 | usd |
| CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
161938000 | usd |
| CY2023Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
286000 | usd |
| CY2023Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
530000 | usd |
| CY2020Q4 | bark |
Class Of Warrant Or Right Number Of Warrants Called By Each Warrant Or Right Percentage
ClassOfWarrantOrRightNumberOfWarrantsCalledByEachWarrantOrRightPercentage
|
0.3333 | shares |
| CY2024Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1479000 | usd |
| CY2023Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2137000 | usd |
| CY2024Q2 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
711000 | usd |
| CY2023Q2 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
1379000 | usd |
| CY2024Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-215000 | usd |
| CY2023Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1583000 | usd |
| CY2024Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-10039000 | usd |
| CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-11663000 | usd |
| CY2024Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10039000 | usd |
| CY2024Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-10039000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11663000 | usd |
| CY2023Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-11663000 | usd |
| CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.06 | |
| CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.06 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
177681579 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
177681579 | shares |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
139383000 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10039000 | usd |
| CY2024Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
145000 | usd |
| CY2024Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
0 | usd |
| CY2024Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
193000 | usd |
| CY2024Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
255000 | usd |
| CY2024Q2 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
4286000 | usd |
| CY2024Q2 | bark |
Adjustments To Additional Paid In Capital Excise Tax From Stock Repurchases
AdjustmentsToAdditionalPaidInCapitalExciseTaxFromStockRepurchases
|
-43000 | usd |
| CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2941000 | usd |
| CY2024Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
21000 | usd |
| CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
128060000 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10039000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11663000 | usd |
| CY2024Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2879000 | usd |
| CY2023Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2868000 | usd |
| CY2024Q2 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
799000 | usd |
| CY2023Q2 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
957000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
1073000 | usd |
| CY2024Q2 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
101000 | usd |
| CY2023Q2 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
185000 | usd |
| CY2024Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2941000 | usd |
| CY2023Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3225000 | usd |
| CY2024Q2 | bark |
Increase Decrease In Inventory Reserves
IncreaseDecreaseInInventoryReserves
|
1229000 | usd |
| CY2023Q2 | bark |
Increase Decrease In Inventory Reserves
IncreaseDecreaseInInventoryReserves
|
600000 | usd |
| CY2024Q2 | bark |
Fair Value Adjustment Of Warrants And Derivatives
FairValueAdjustmentOfWarrantsAndDerivatives
|
391000 | usd |
| CY2023Q2 | bark |
Fair Value Adjustment Of Warrants And Derivatives
FairValueAdjustmentOfWarrantsAndDerivatives
|
-1304000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-637000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1427000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-2521000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-11269000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
999000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1602000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-343000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
125000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2396000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-14824000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
542000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-1427000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-1281000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-917000 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-1625000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
474000 | usd |
| CY2024Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1792000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10741000 | usd |
| CY2024Q2 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
2043000 | usd |
| CY2023Q2 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
2972000 | usd |
| CY2024Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2043000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2972000 | usd |
| CY2024Q2 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
54000 | usd |
| CY2023Q2 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
58000 | usd |
| CY2024Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
145000 | usd |
| CY2023Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
81000 | usd |
| CY2024Q2 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
193000 | usd |
| CY2023Q2 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
286000 | usd |
| CY2024Q2 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
255000 | usd |
| CY2023Q2 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
530000 | usd |
| CY2024Q2 | bark |
Payments For Excise Tax From Stock Repurchases
PaymentsForExciseTaxFromStockRepurchases
|
43000 | usd |
| CY2023Q2 | bark |
Payments For Excise Tax From Stock Repurchases
PaymentsForExciseTaxFromStockRepurchases
|
0 | usd |
| CY2024Q2 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
4286000 | usd |
| CY2023Q2 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | usd |
| CY2024Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-4300000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-221000 | usd |
| CY2024Q2 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
21000 | usd |
| CY2023Q2 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2000 | usd |
| CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-4530000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-13932000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
130704000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
183068000 | usd |
| CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
126174000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
169136000 | usd |
| CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
117795000 | usd |
| CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
163923000 | usd |
| CY2024Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
8379000 | usd |
| CY2023Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
5213000 | usd |
| CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
126174000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
169136000 | usd |
| CY2024Q2 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | usd |
| CY2023Q2 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
97000 | usd |
| CY2024Q2 | us-gaap |
Interest Paid Net
InterestPaidNet
|
50000 | usd |
| CY2023Q2 | us-gaap |
Interest Paid Net
InterestPaidNet
|
45000 | usd |
| CY2024Q2 | bark |
Number Of Product Lines
NumberOfProductLines
|
2 | productcategory |
| CY2024Q2 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes estimates and assumptions about future events that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates, judgments and assumptions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company bases its estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed consolidated financial statements. The most significant estimates relate to determination of fair value of the Company’s allowance for uncollectible accounts receivable, excess and obsolete inventory, stock-based compensation, stand-alone selling price of Direct to Consumer offerings and fair value of right-of-use assets. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and records adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.</span></div> | |
| CY2024Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
0 | shares |
| CY2024Q2 | bark |
Number Of Leases Secured By Letter Of Credit
NumberOfLeasesSecuredByLetterOfCredit
|
4 | lease |
| CY2024Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
8400000 | usd |
| CY2024Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
5200000 | usd |
| CY2024Q2 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk and Major Customers and Suppliers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with two financial institutions.</span></div>The Company’s accounts receivable are derived from sales contracts with large retail customers. The Company maintains reserves for potential credit losses on customer accounts when deemed necessary. | |
| CY2024Q2 | bark |
Number Of Financial Institutions Cash And Cash Equivalents Deposits
NumberOfFinancialInstitutionsCashAndCashEquivalentsDeposits
|
2 | financialinstitution |
| CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7100000 | usd |
| CY2024Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7700000 | usd |
| CY2023Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
6600000 | usd |
| CY2024Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
116212000 | usd |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
120591000 | usd |
| CY2024Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
26500000 | usd |
| CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
26000000.0 | usd |
| CY2023Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
27800000 | usd |
| CY2024Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
40027000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
39926000 | usd |
| CY2023Q3 | srt |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
7500000 | usd |
| CY2024Q2 | srt |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
15000000 | usd |
| CY2024Q2 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
3002432 | shares |
| CY2024Q2 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
4300000 | usd |
| CY2024Q2 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.43 | |
| CY2024Q2 | us-gaap |
Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
|
0 | shares |
| CY2024Q2 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
12000000.0 | usd |
| CY2024Q2 | bark |
Share Repurchase Program Number Of Programs During Period
ShareRepurchaseProgramNumberOfProgramsDuringPeriod
|
2 | program |
| CY2021Q2 | bark |
Share Based Compensation Arrangement By Share Based Payment Award Options Minimum Exercise Price Grant Date Fair Value Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMinimumExercisePriceGrantDateFairValuePercentage
|
1 | |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1087500 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
25000 | shares |
| CY2024Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.37 | |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.08 | |
| CY2024Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2941000 | usd |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3225000 | usd |
| CY2024Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2941000 | usd |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3225000 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
31836000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
32793000 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
31836000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
32793000 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
5416000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
5294000 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
41196000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
42599000 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
46612000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
47893000 | usd |
| CY2024Q2 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | usd |
| CY2023Q2 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | usd |
| CY2024Q2 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
1800000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
2000000.0 | usd |
| CY2024Q2 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-1300000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-900000 | usd |
| CY2024Q1 | us-gaap |
Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
|
3 | plaintiff |
| CY2024Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2024Q2 | bark |
Other Miscellaneous Nonoperating Income Expense Net
OtherMiscellaneousNonoperatingIncomeExpenseNet
|
176000 | usd |
| CY2023Q2 | bark |
Other Miscellaneous Nonoperating Income Expense Net
OtherMiscellaneousNonoperatingIncomeExpenseNet
|
279000 | usd |
| CY2024Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
391000 | usd |
| CY2023Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1304000 | usd |
| CY2024Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-215000 | usd |
| CY2023Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1583000 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-10039000 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-10039000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-11663000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-11663000 | usd |
| CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
175561535 | shares |
| CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
175561535 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
177681579 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
177681579 | shares |
| CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.06 | |
| CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.06 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | |
| CY2024Q2 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | segment |
| CY2024Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
116212000 | usd |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
120591000 | usd |
| CY2024Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
42946000 | usd |
| CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
47555000 | usd |
| CY2024Q2 | us-gaap |
Gross Profit
GrossProfit
|
73266000 | usd |
| CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
73036000 | usd |
